Int J Stomatol

Inter J Stomatol ›› 2018, Vol. 45 ›› Issue (4): 425-432.doi: 10.7518/gjkq.2018.04.010

• Reviews • Previous Articles     Next Articles

Long non-coding RNA and its relationship with oral cancer

Song Hongning1, Wang Xuxia2, Zhang Jun2   

  1. 1. Dept. of Oral and Maxillofacial Surgery, Affiliated Hospital of Taishan Medical University, Taian 271000, China;
    2. Dept. of Oral and Maxillofacial Surgery, School of Stomatology, Shandong University, Jinan 250012, China
  • Received:2017-08-13 Revised:2018-03-27 Online:2018-07-02 Published:2018-07-02
  • Supported by:
    This study was supported by Science and Technology Development Funds of Shandong Province (2010GSF10239) and Science and Technology Development Special Funds of Shandong Province (2012G0021852).

RichHTML

3

PDF (PC)

625

Abstract: Long non-coding RNA (lncRNA) is a family of non-protein-coding RNAs with length of more than 200 nucleotides. These lncRNAs have gained considerable attention and recently emerged as main participants in biological processes. An increasing number of studies showed that lncRNAs play important roles in diverse cellular processes, including proliferation, differentiation, apoptosis, migration, invasion and chromatin remodelling. Importantly, lncRNAs are increasingly recognised in cancer biology and prognosis. Multiple studies also indicated that lncRNAs play important roles in tumour growth and metastasis and poor prognosis in multiple tumour types. These RNAs may also act as a potential biomarker and therapeutic target for human cancers. Furthermore, lncRNA deregulation is observed in multiple tumours. However, the molecular mechanism of lncRNAs in cancer initiation, progression and metastasis remains poorly understood. In this review, we highlight the recent findings on lncRNAs in cancer pathogenesis and summarise an overview of current knowledge concerning the expression and role of lncRNA in various cancers. Additionally, lncRNAs emerged as a new class of promising cancer biomarkers. Independent studies demonstrated the feasibility of their use as tools in the diagnosis and prognosis of different types of malignancies and in the prediction and possible monitoring treatment response. The role of lncRNAs in cancers is an emerging field of study. Although our understanding about the role of lncRNAs in the onset and progression of cancers is still in its infancy, further understanding the activities of lncRNAs will secure improved treatment options for cancer patients.

Key words: long non-coding RNA, cancer, cancer biomarker

CLC Number: 

  • Q52

TrendMD: 
[1] Djebali S, Davis CA, Merkel A, et al.Landscape of transcription in human cells[J]. Nature, 2012, 489(7414): 101-108.
[2] Liu J, Cheng G, Yang H, et al.Reciprocal regulation of long noncoding RNAs THBS4-003 and THBS4 control migration and invasion in prostate cancer cell lines[J]. Mol Med Rep, 2016, 14(2): 1451-1458.
[3] Okazaki Y, Furuno M, Kasukawa T, et al.Analysis of the mouse transcriptome based on functional an-notation of 60,770 full-length cDNAs[J]. Nature, 2002, 420(6915): 563-573.
[4] Al-Tassan NA, Whiffin N, Hosking FJ, et al.A new GWAS and meta-analysis with 1 000 genomes im-putation identifies novel risk variants for colorectal cancer[J]. Sci Rep, 2015, 5: 10442.
[5] Maass PG, Luft FC, Bähring S.Long non-coding RNA in health and disease[J]. J Mol Med, 2014, 92(4): 337-346.
[6] St laurent G, Wahlestedt C, Kapranov P. The land-scape of long noncoding RNA classification[J]. Trends Genet, 2015, 31(5): 239-251.
[7] Kan JY, Wu DC, Yu FJ, et al.Chemokine (C-C motif) ligand 5 is involved in tumorassociated den-dritic cell-mediated colon cancer progression through non-coding RNA MALAT-1[J]. J Cell Physiol, 2015, 230(8): 1883-1894.
[8] Schaukowitch K, Kim TK.Emerging epigenetic mechanisms of long non-coding RNAs[J]. Neuro-science, 2014, 264: 25-38.
[9] Maass PG, Luft FC, Bähring S.Long non-coding RNA in health and disease[J]. J Mol Med, 2014, 92(4): 337-346.
[10] Zhao XY, Li S, Wang GX, et al.A long noncoding RNA transcriptional regulatory circuit drives thermo-genicadipocyte differentiation[J]. Mol Cell, 2014, 55(3): 372-382.
[11] Monnier P, Martinet C, Pontis J, et al.H19 lncRNA controls gene expression of the imprinted gene net-work by recruiting MBD1[J]. Proc Natl Acad Sci USA, 2013, 110(51): 20693-20698.
[12] Charlton J, Williams RD, Sebire NJ, et al.Compara-tive methylome analysis identifies new tumour sub-types and biomarkers for transformation of nephro-genic rests into Wilms tumour[J]. Genome Med, 2015, 7(1): 11.
[13] Lv J, Ma L, Chen XL, et al.Downregulation of lnc-RNA H19 and MiR-675 promotes migration and invasion of human hepatocellular carcinoma cells through AKT/GSK-3β/Cdc25A signaling pathway[J]. J Huazhong Univ Sci Technol (Med Sci), 2014, 34(3): 363-369.
[14] Li H, Yu B, Li J, et al.Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer[J]. Oncotarget, 2014, 5(8): 2318-2329.
[15] Zhou X, Ye F, Yin C, et al.The interaction between MiR-141 and lncRNA-H19 in regulating cell pro-liferation and migration in gastric cancer[J]. Cell Physiol Biochem, 2015, 36(4): 1440-1452.
[16] Zhang HM, Yang FQ, Chen SJ, et al.Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma[J]. Tumour Biol, 2015, 36(4): 2947-2955.
[17] Jadaliha M, Zong X, Malakar P, et al.Functional and prognostic significance of long non-coding RNA MALAT1 as a metastasis driver in ER negative ly-mph node negative breast cancer[J]. Oncotarget, 2016, 7(26): 40418-40436.
[18] Wang W, Zhu Y, Li S, et al.Long noncoding RNA MALAT1 promotes malignant development of eso-phageal squamous cell carcinoma by targeting β- catenin via Ezh2[J]. Oncotarget, 2016, 7(18): 25668-25682.
[19] Dong Y, Liang G, Yuan B, et al.MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway[J]. Tumour Biol, 2015, 36(3): 1477-1486.
[20] Hauptman N, Glavač D.Long non-coding RNA in cancer[J]. Int J Mol Sci, 2013, 14(3): 4655-4669.
[21] Endo H, Shiroki T, Nakagawa T, et al.Enhanced ex- pression of long non-coding RNA HOTAIR is asso-ciated with the development of gastric cancer[J]. PLoS One, 2013, 8(10): e77070.
[22] Huang J, Ke P, Guo L, et al.Lentivirus-mediated RNA interference targeting the long noncoding RNA HOTAIR inhibits proliferation and invasion of en-dometrial carcinoma cells in vitro and in vivo[J]. Int J Gynecol Cancer, 2014, 24(4): 635-642.
[23] Fang K, Liu P, Dong S, et al.Magnetofection based on superparamagnetic iron oxide nanoparticle-me-diated low lncRNA HOTAIR expression decreases the proliferation and invasion of glioma stem cells[J]. Int J Oncol, 2016, 49(2): 509-518.
[24] Gutschner T, Diederichs S.The hallmarks of cancer: a long non-coding RNA point of view[J]. RNA Biol, 2012, 9(6): 703-719.
[25] Peng W, Wu G, Fan H, et al.Long noncoding RNA SPRY4-IT1 predicts poor patient prognosis and pro-motes tumorigenesis in gastric cancer[J]. Tumour Biol, 2015, 36(9): 6751-6758.
[26] Jing W, Gao S, Zhu M, et al.Potential diagnostic value of lncRNA SPRY4-IT1 in hepatocellular car-cinoma[J]. Oncol Rep, 2016, 36(2): 1085-1092.
[27] Smith CM, Steitz JA.Classification of gas5 as a multi-small-nucleolar-RNA (snoRNA) host gene and a member of the 5’-terminal oligopyrimidine gene family reveals common features of snoRNA host genes[J]. Mol Cell Biol, 1998, 18(12): 6897-6909.
[28] Pickard MR, Mourtada-Maarabouni M, Williams GT.Long non-coding RNA GAS5 regulates apop-tosis in prostate cancer cell lines[J]. Biochim Biophys Acta, 2013, 1832(10): 1613-1623.
[29] Liu Z, Wang W, Jiang J, et al.Downregulation of GAS5 promotes bladder cancer cell proliferation, partly byregulating CDK6[J]. PLoS One, 2013, 8(9): e73991.
[30] Chen L, Yang H, Xiao Y, et al.Lentiviral-mediated overexpression of long non-coding RNA GAS5 re-duces invasion by mediating MMP2 expression and activity in human melanoma cells[J]. Int J Oncol, 2016, 48(4): 1509-1518.
[31] Lu KH, Li W, Liu XH, et al.Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and in-duces apoptosis by affecting p53 expression[J]. BMC Cancer, 2013, 13: 461.
[32] Qin R, Chen Z, Ding Y, et al.Long non-coding RNA MEG3 inhibits the proliferation of cervical carcinoma cells through the induction of cell cycle arrest and apoptosis[J]. Neoplasma, 2013, 60(5): 486-492.
[33] Chang L, Wang G, Jia T, et al.Armored long non-coding RNA MEG3 targeting EGFR based on re-combinant MS2 bacteriophage virus-like particles against hepatocellular carcinoma[J]. Oncotarget, 2016, 7(17): 23988-24004.
[34] Flockhart RJ, Webster DE, Qu K, et al.BRAFV600E remodels the melanocyte transcriptome and induces BANCR to regulate melanoma cell migration[J]. Genome Res, 2012, 22(6): 1006-1014.
[35] Sun M, Liu XH, Wang KM, et al.Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesen-chymal transition[J]. Mol Cancer, 2014, 13(1): 68.
[36] Gibb EA, Enfield KS, Stewart GL, et al.Long non-coding RNAs are expressed in oral mucosa and altered in oral premalignant lesions[J]. Oral Oncol, 2011, 47(11): 1055-1061.
[37] Wu Y, Zhang L, Zhang L, et al.Long non-coding RNA HOTAIR promotes tumor cell invasion and metastasis by recruiting EZH2 and repressing E- cadherin in oral squamous cell carcinoma[J]. Int J Oncol, 2015, 46(6): 2586-2594.
[38] Jia LF, Wei SB, Gan YH, et al.Expression, regula-tion and roles of miR-26a and MEG3 in tongue squa-mous cell carcinoma[J]. Int J Cancer, 2014, 135(10): 2282-2293.
[39] Gao W, Chan JY, Wong TS.Long non-coding RNA deregulation in tongue squamous cell carcinoma[J].Biomed Res Int, 2014, 2014: 405860.
[1] He Zimu, Li Fenglan. Present application of digital oral positioning stents in radiotherapy of head and neck tumor [J]. Int J Stomatol, 2024, 51(1): 28-35.
[2] Fu Yu, He Wei, Huang Lan. Ferroptosis and its implication in oral diseases [J]. Int J Stomatol, 2024, 51(1): 36-44.
[3] Wu Jiamin,Xia Bin,Yang Hefeng,Xu Biao.. Research progress on cancer-associated fibroblasts in the tumor microenvironment of oral squamous cell carcinoma [J]. Int J Stomatol, 2023, 50(6): 711-717.
[4] Jiang Yueying,He Yutian,Li Ting,Zhou Ronghui.. Research progress on the application of near infrared fluorescence probe in the diagnosis of oral cancer [J]. Int J Stomatol, 2023, 50(4): 407-413.
[5] Sun Xiaoqian, Zhang Jun. Advances in the effects of mechanical environment on the biological behaviors and mechanism of head and neck cancer [J]. Int J Stomatol, 2023, 50(4): 414-418.
[6] Fan Lin,Sun Jiang.. Application of microneedles in stomatology [J]. Int J Stomatol, 2023, 50(4): 472-478.
[7] Lin Huiping,Xu Ting,Lin Jun.. Research progress on artificial intelligence techniques in diagnosis of oral cancer and potentially malignant disorders [J]. Int J Stomatol, 2023, 50(2): 138-145.
[8] Wang Taiping,Shi Xinglian,Li Zhezhen,Liu Mei,Jiang Jianhong. Analysis of psychological factors and intervention in patients with oral cancer [J]. Int J Stomatol, 2023, 50(2): 203-209.
[9] Yang Mingyan,Zhang Fan,Zhao Lei. Research progress on oral flora changes affecting the course of radiotherapy and chemotherapy-related oral mucositis [J]. Int J Stomatol, 2023, 50(1): 43-51.
[10] Luo Wanyi,Han Juxi,Zhou Xuedong,Peng Xian,Zheng Xin. Research progress on the mechanism of Fusobacterium nucleatum promoting the initiation and development of colorectal cancer [J]. Int J Stomatol, 2023, 50(1): 52-60.
[11] Chen Huiyu,Bai Mingru,Ye Ling.. Progress in understanding the correlations between semaphorin 3A and common oral diseases [J]. Int J Stomatol, 2022, 49(5): 593-599.
[12] Liu Jiacheng,Meng Zhaosong,Li Hongjie,Sui Lei. The role of follistatin in oral and maxillofacial development and its therapeutic application prospect [J]. Int J Stomatol, 2021, 48(5): 556-562.
[13] Fu Shijin,Zeng Kan,Li Xin,Yang Jing,Wang Chenglin,Ye Ling. Preliminary study on osteoprotegerin/receptor activator of nuclear factor-κB ligand expression in mandible and femur on site selectivity of bone metastasis of lung cancer cells [J]. Int J Stomatol, 2020, 47(5): 538-546.
[14] Kong Lixin,Ren Biao,Cheng Lei. Research progress on regulation of cyclooxygenase-2/prostaglandin E2 pathway on oral cancer [J]. Int J Stomatol, 2020, 47(4): 431-438.
[15] Huang Lu,Dai Jie,Wu Yanmin. Application of saliva biomarkers in oral cancer screening [J]. Int J Stomatol, 2020, 47(1): 68-75.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[2] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[3] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[4] . [J]. Foreign Med Sci: Stomatol, 1999, 26(06): .
[5] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[6] . [J]. Foreign Med Sci: Stomatol, 1999, 26(05): .
[7] . [J]. Foreign Med Sci: Stomatol, 1999, 26(04): .
[8] . [J]. Foreign Med Sci: Stomatol, 1999, 26(04): .
[9] . [J]. Foreign Med Sci: Stomatol, 2004, 31(02): 126 -128 .
[10] . [J]. Inter J Stomatol, 2008, 35(S1): .